R. Lozano

发表

Therapeutic Response to Octreotide in Patients with Refractory CPT-11 Induced Diarrhea

J. Ajani, B. Pro, R. Lozano, 2001, Investigational New Drugs.

Modified cisplatin/interferon α‐2b/doxorubicin/5‐fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma

Manal M. Hassan, J. Shindoh, S. Curley, 2013, Cancer.

Association between hypothyroidism and hepatocellular carcinoma: A case‐control study in the United States

Manal M. Hassan, M. Spitz, S. Curley, 2009, Hepatology.

Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.

L. Ellis, S. Curley, J. Vauthey, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide.

L. Ellis, Y. Patt, M. Hassan, 2000, American journal of clinical oncology.

A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma

M. Thomas, J. Abbruzzese, T. Arima, 2008, Journal of Cancer Research and Clinical Oncology.

Curing hepatocellular carcinomatosis with biologic therapy and surgery: Achieving the impossible?

E. Abdalla, M. Thomas, J. Vauthey, 2008, Journal of surgical oncology.

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.

Douglas B. Evans, J. Ajani, James C Yao, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thalidomide in the treatment of patients with hepatocellular carcinoma

Manal M. Hassan, M. Hassan, J. Abbruzzese, 2005, Cancer.

Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.

A. Hoque, Y. Patt, D. Jones, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.

Manal M. Hassan, S. Curley, W. Chan, 2009, Journal of hepatology.

Phase II Trial of Cisplatin, Interferon α-2b, Doxorubicin, and 5-Fluorouracil for Biliary Tract Cancer

Manal M. Hassan, L. Ellis, S. Curley, 2001 .

Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer.

C. Charnsangavej, I. Raijman, A. Hoque, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.

Manal M. Hassan, L. Ellis, S. Curley, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

Manal M. Hassan, S. Curley, E. Abdalla, 2010, Cancer.

Phase I I T rial o f S ystemic C ontinuous F luorouracil a nd Subcutaneous R ecombinant I nterferon A lfa-2b f or T reatment of H epatocellular C arcinoma

Manal M. Hassan, L. Ellis, S. Curley, 2003 .

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma

Manal M. Hassan, L. Ellis, S. Curley, 2004, Cancer.

Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case‐control study

Manal M. Hassan, L. Ellis, M. Spitz, 2008, International journal of cancer.

V‐CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials

Jeffrey S. Morris, Manal M. Hassan, A. Rashid, 2011, Cancer.

Feasibility of Adjuvant Hepatic Arterial Infusion of Chemotherapy After Radiofrequency Ablation With or Without Resection in Patients With Hepatic Metastases From Colorectal Cancer

L. Ellis, B. Fornage, F. Izzo, 2003, Annals of Surgical Oncology.

Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.

L. Ellis, S. Curley, E. Delpassand, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon alpha 2B, doxorubicin, and 5-fluorouracil: a communication.

L. Ellis, C. Charnsangavej, C. Carrasco, 1999, American Journal of Clinical Oncology.

Phase II Trial of Cisplatin , Interferon-2 b , Doxorubicin , and 5-Fluorouracil for Biliary Tract Cancer 1

Manal M. Hassan, L. Ellis, S. Curley, 2001 .

Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case‐control study

Manal M. Hassan, L. Ellis, M. Spitz, 2008, International journal of cancer.